Kakumanu, Sravya
Manns, Braden J.
Tran, Sophia
Saunders-Smith, Terry
Hemmelgarn, Brenda R.
Tonelli, Marcello
Tsuyuki, Ross
Ivers, Noah
Southern, Danielle
Bakal, Jeff
Campbell, David J. T.
Funding for this research was provided by:
Alberta Innovates - Health Solutions (NA, 201300672)
Canadian Institutes of Health Research (148441)
Cumming School of Medicine, University of Calgary (CRF15-018)
Article History
Received: 25 May 2019
Accepted: 13 August 2019
First Online: 7 October 2019
Ethics approval and consent to participate
: The ethics ID for the ACCESS trial is REB13-1241. No ethical approval was required specifically for this study.
: Not applicable.
: Dr. Tsuyuki has received investigator-initiated grants from Merck Canada, AstraZeneca Canada, and Sanofi Canada. He has given paid presentations for Merck Canada and Sanofi Canada.